Table 2.
Prevalence of BAF250a (ARID1A), MMR and p53 immunohistochemical expression and in relation to age and histological subtype
| BAF250a+ | BAF250a – | P | MMR retained | MMR lost | P | p53 normal | p53 aberrant | P | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Age (years), mean | 68.9 | 62.8 | 0.0003 | 67.6 | 66.4 | 0.471 | 66.2 | 68.3 | 0.201 | ||||||
| Histological type | <0.0001 | <0.0001 | <0.0001 | ||||||||||||
| Endometrioid | 44 | 54% | 38 | 46% | 35 | 43% | 47 | 57% | 67 | 82% | 15 | 18% | |||
| Serous | 80 | 91% | 8 | 9% | 79 | 90% | 9 | 10% | 20 | 22% | 68 | 78% | |||
| Clear cell | 6 | 60% | 4 | 40% | 9 | 90% | 1 | 10% | 9 | 90% | 1 | 10% | |||
| Mixed | 5 | 50% | 5 | 50% | 4 | 40% | 6 | 60% | 8 | 80% | 2 | 20% | |||
| Total | 135 | 71% | 55 | 29% | 127 | 67% | 63 | 33% | 104 | 55% | 86 | 45% | |||